> Concomitant use of SPRAVATO with CNS depressants (e.g., be nzodiazepines, OPIOIDS, alcohol) may increase sedation ,which therefore should be closely monitored . Blood pressure should be closely monitored when SPRAVATO is used concomitantly with psychostimulants (e.g., amphetamines, METHYLPHENIDATE, MODAFINIL , arm odafinil) or other medicinal products that may increase blood pressure (e.g. ,xanthin ederivatives, ergometrine, THYROID HORMONES, VASOPRESSIN, or MAOIs, such as, TRANYLCYPROMINE, SELEGILINE, PHENELZINE).

